Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Opens Gateway for NHGRI and NCI

NEW YORK, May 5 (GenomeWeb News) - Invitrogen yesterday announced an agreement with the National Human Genome Research Institute and the National Cancer Institute to institute open access to the company's Gateway and SuperScript technologies for use with the Mammalian Gene Collection program.

 

Gateway is a method for cloning DNA sequences for functional study. Additionally, some Gateway vectors allow for the synthesis of protein products. Under Invitrogen's licensing policies, academic and government researchers can create and distribute Gateway clones and expression clones to any entity without royalties or licensing fees.

 

The Mammalian Gene Collection program is an NIH-funded effort to generated sequenced full-length cDNAs.

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.